Marshall Wace North America’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Marshall Wace North America’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-31,061	Closed	-$855K	–	1852
2021 Q2	$855K	Buy	+31,061	New	+$610K	﹤0.01%	1054
2019 Q4	–	Sell	-45,472	Closed	-$451K	–	1721
2019 Q3	$451K	Buy	+45,472	New	+$429K	﹤0.01%	830

Marshall Wace North America's TBIO Position: Q3 2021 in Review

Marshall Wace North America sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 31,061 shares — an estimated $855K sold.

Marshall Wace North America first reported a position in TBIO in Q3 2019 and held it in 2 quarters. The position peaked at $855K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Marshall Wace North America reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 31,061 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $855K.
Marshall Wace North America first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
Marshall Wace North America's Translate Bio, Inc. Common Stock position peaked at $855K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.